Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lactobacillus casei capable of adjusting balance of allergic asthma Th2/Th1 and application of lactobacillus casei

A technology of Lactobacillus casei and viable count, applied in the field of Lactobacillus casei, can solve problems such as poor effect, unclear effect, poor compliance, etc., achieves great application prospects, and improves the effect of pulmonary inflammatory response

Active Publication Date: 2020-01-03
JIANGNAN UNIV
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, since most bronchodilator drugs and anti-inflammatory drugs need to be administered by intravenous injection or inhalation, the patient's compliance with these drugs is poor, which leads to repeated attacks of the patient's disease, and over time it will cause the patient's Severe complications such as emphysema and pulmonary heart disease
[0007] Although probiotic preparations are relatively safe and healthy, most of the probiotic preparations on the market may also have the disadvantage of being slow to take effect due to the fact that the currently discovered probiotics that can relieve the symptoms of allergic asthma may have poor or unclear effects. , or have the defect that the role relationship is not clear
[0008] Therefore, there is an urgent need to find a probiotic that is highly specific to allergic asthma and has a strong ability to alleviate allergic asthma to solve the problem of unclear relationship between the effects of existing probiotic preparations for allergic asthma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lactobacillus casei capable of adjusting balance of allergic asthma Th2/Th1 and application of lactobacillus casei
  • Lactobacillus casei capable of adjusting balance of allergic asthma Th2/Th1 and application of lactobacillus casei
  • Lactobacillus casei capable of adjusting balance of allergic asthma Th2/Th1 and application of lactobacillus casei

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment 1: Screening and identification of Lactobacillus casei

[0055] 1. Screening:

[0056] Taking infant feces from Wuxi, Jiangsu as the sample, the sample was pretreated and stored in a -80°C refrigerator in about 20% glycerin. After taking it out and thawing, mix the sample and add 0.5mL sample to 4.5mL, then add 0.9 Perform gradient dilution with % normal saline, select the appropriate gradient dilution and spread it on the MRS solid medium, culture at 37°C for 48 hours, pick typical colonies to streak and purify on the MRS solid medium, pick a single colony and transfer to MRS The liquid medium was enriched and preserved in 30% glycerol to obtain strain CCFM1073.

[0057] 2. Identification:

[0058] The 16S rDNA of CCFM1073 was amplified and sequenced, and the sequence was compared in NCBI. The results showed that the strain was Lactobacillus casei, and it was named CCFM1073 as Lactobacillus casei.

Embodiment 2

[0059] Embodiment 2: the cultivation of Lactobacillus casei

[0060] Lactobacillus casei (Lactobacillus casei) CCFM1073 was inserted into MRS solid medium and cultured at 37°C for 48 hours, and its colonies were observed under a microscope. It was found that the colonies were rough, off-white, and sometimes slightly yellow. The shape of the bacteria varies in length, and the two ends are square, often forming chains.

[0061] Insert Lactobacillus casei (Lactobacillus casei) CCFM1073 into MRS liquid medium and culture at 37°C for 18 hours, then transfer to fresh MRS liquid medium, cultivate under the same conditions for 18 hours, centrifuge the bacteria at 6000g for 15 minutes, wash the bacteria with 0.9% normal saline Centrifuge again at 6000 g for 10 min after inoculation to obtain bacterial cells, resuspend with 30% sucrose solution, and freeze at -80°C until use.

Embodiment 3

[0062] Example 3: Effect of Lactobacillus casei on pulmonary inflammation in allergic asthmatic mice

[0063] The 6-week-old SPF grade BALB / c female mice were divided into 6 groups, namely the normal group, the model group and the experimental group. The L.GG prevention group of Bacillus GG (ATCC53103), the L.casei1 prevention group of Lactobacillus casei 1 and the L.casei2 prevention group of Lactobacillus casei 2 by oral administration, 6 animals in each group, were raised in the Experimental Animal Center of Jiangnan University , fed with common feed, constant temperature 21-26°C, humidity 40-70%, noise less than or equal to 60dB, animal illumination 15-20LX (all animal experiment procedures were reviewed and approved by the Animal Welfare and Ethics Management Committee of Jiangnan University).

[0064] The experiment lasted for 6 weeks (5 days a week), and the model was established in the 2nd to 6th weeks. The mice in the model group and the experimental group were anesth...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a lactobacillus casei capable of adjusting balance of allergic asthma Th2 / Th1 and application of the lactobacillus casei, and belongs to the technical field of microorganisms and the technical field of medicine. The lactobacillus casei has the effect of relieving allergic asthma, the effect is specifically embodied in that (1) the lung inflammation response of allergic asthma mice is significantly lowered; (2) generation of total immune globulin IgE in serum of the allergic asthma mice is significantly inhibited; (3) generation of dust mite specific immunoglobulin IgG1in the serum of the allergic asthma mice is significantly inhibited; (4) the content of dust mite specific immunoglobulin IgG2a in the serum of the allergic asthma mice is not changed; and (5) the balance of Th2 / Th1 is significantly restored. Therefore, the lactobacillus casei has great application prospects in preparation of products for preventing and / or treating allergic asthma.

Description

technical field [0001] The invention relates to a strain of Lactobacillus casei capable of regulating the Th2 / Th1 balance of allergic asthma and an application thereof, belonging to the technical field of microbes and the technical field of medicine. Background technique [0002] The worldwide prevalence is on the rise. Over the past ten years, there have been about 100 million allergic asthma patients in the world; the prevalence and mortality of allergic asthma in the United States, the United Kingdom, Australia, New Zealand and other countries have gradually increased Trend: There are more than 10 million asthma patients in China, and the average prevalence rate of allergic asthma in the population is about 1%, among which children can reach 3%. In susceptible individuals, this inflammation can cause recurrent episodes of wheezing, shortness of breath, chest tightness, and / or coughing, which can lead to life-threatening complications such as respiratory arrest and respira...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20A23L29/00A23L33/135A61K35/747A61P11/06A61P37/08C12R1/245
CPCA61K35/747A23L29/065A23L33/135A61P11/06A61P37/08C12N1/20C12N1/205C12R2001/245
Inventor 陆文伟陈卫李凌智翟齐啸张秋香王鸿超赵建新张灏
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com